Context: Uterine leiomyoma, the most common tumors found in the women of the reproductive age, may cause abnormal uterine bleeding and be life threatening. Compared with myometrium, leiomyoma contains excessive extracellular matrix (ECM). However, the pathological roles of ECM in the development of leiomyoma remain largely unknown. Integrins are the major adhesion molecules on cell surface to interact with ECM. The interactions of ECM with integrins regulate cell adhesion and initiate signals for cell growth, differentiation, and migration.
U
terine leiomyomas, known as fibroids, are benign tumors that originate from the smooth muscle layer, the myometrium. Although the etiology remains unknown, leiomyoma is the most common tumor found in women of reproductive age. The incidence of uterine leiomyomas ranges from 20% to 70% and increases with increasing age (1) . In the United States, there are approximately 200 000 hysterectomies performed each year due to the presence of leiomyomas (2) . The symptoms of leiomyomas are increased urinary frequency, dysmenorrhea, abnormal uterine bleeding, and infertility (1) .
One of the characteristics of leiomyomal tissues is dysregulated and excessive production of extracellular matrix (ECM). It has been reported that leiomyomas contain 50% more ECM components than the myometrium. The ECM components of leiomyomas include collagens, fibronectin, and proteoglycans (3, 4) . It has been found that collagen fibrils of leiomyomas are more abundant, loosely packed, and arrayed in a nonparallel manner compared with myometrium (4, 5) . In addition, cell shape was angular and actin structure is disordered in leiomyomas (6) .
Adhesion to the ECM is essential for cell survival, growth, morphology, and migration. Cell adhesion to the ECM induces cell surface structures associated with the matrix, which is termed cell-matrix adhesions. So far, cell-ECM adhesions are known to be composed of more than 150 different proteins to form focal adhesions (7) . These proteins and adhesion receptors provide a scaffold linking ECM to actin cytoskeleton and a response to different environmental cues and transmit signals to the intracellular environment (8) . Aberrations in ECM organization and cell-ECM interaction contribute widely to diseases (9, 10) . For example, progressive extracellular remodeling in chronic atherosclerotic and fibrotic diseases eventually leads to a loss of tissue integrity (9, 11) .
Cell-matrix adhesions are mainly regulated by integrins. They are transmembrane receptors that link the cytoskeleton and ECM. Integrins are heterodimers, composed of noncovalently bound ␣-and ␤-subunits. In humans, 18 ␣-subunits and 8 ␤-subunits have been identified and can form 24 different combinations. These ␣␤-combinations provide ligand specificity to the particular integrins (12) . For instance, association of different ␣-and ␤1-subunits bind to various ECM molecules. ␣1␤1, ␣2␤1, ␣10␤1, and ␣11␤1 are bound by collagen; ␣4␤1, ␣5␤1, ␣8␤1, and ␣v␤1 are receptors for fibronectin; ␣1␤1, ␣2␤1, ␣3␤1, ␣6␤1, and ␣7␤1 are receptors for laminin, and ␣v␤1 is for vitronectin binding (7) .
The binding of integrins by ECM molecules initiates multiple signaling cascades including protein tyrosine and serine/threonine kinase pathways (13) . Most integrins recruit focal adhesion kinase (FAK), which functions as a phosphorylation-regulated scaffold to recruit and activate src, src-family kinase, and phosphatidylinositol 3-kinase. FAK also activates ERK, which regulates the expression of cell cycle proteins such as cyclin D1 and the cyclindependent kinase inhibitor family (14) . Taken together, the pathways that integrin activates through the FAK are essential for cell proliferation, survival, and migration (10, 15) .
Despite the well-recognized excessive production of ECMs in leiomyoma, little is known about their functions in the disease pathogenesis. In this study, we aimed to evaluate the expression levels of ECM receptors, the integrins, and to investigate the pathological role of ECMintegrin axis in the development and/or progression of leiomyoma.
Materials and Methods

Antibodies
The mouse anti-integrin-␤1, anti-integrin-␤3, anti-FAK, and antipaxillin antibodies were purchased from BD Biosciences (San Diego, California). The rabbit anti-phosphorylated FAK (pY397) antibody was from Invitrogen (Carlsbad, California). The mouse anti-␤-actin antibody was from Sigma-Aldrich, Inc (St Louis, MO), and the rabbit anticyclin D1 antibody was from Santa Cruz Biotechnology (Santa Cruz, California). The horseradish peroxidase-conjugated goat-antirabbit IgG was from Jackson ImmunoResearch (West Grove, Pennsylvania) and the sheep-antimouse IgG was purchased from GE Healthcare Biosciences (Piscataway, New Jersey).
Sample collection and cell isolation
Leiomyomal tissues were obtained from patients who underwent hysterectomy at the Department of Obstetrics and Gynecology at The National Cheng Kung University Hospital. All the patients were premenopausal and received no estrogen-related hormone therapy. All samples were histologically confirmed by pathologists (Supplemental Table 1 , published on The Endocrine Society's Journals Online web site at http://jcem.endojournals.org). Procedures for leiomyomal and myometrial cells isolation were described previously (16) . This study was approved by the Institutional Review Board of National Cheng Kung University Medical Center, and informed consent was obtained from each patient. Purity of cells was confirmed by morphology observation and immunostaining with antibody specific for smooth muscle marker ␣-actin.
Small interfering RNA (siRNA) transfection
Leiomyomal cells were grown until subconfluence. The cells were seeded in 2.5 ϫ 10 5 cells per 3-cm dish and incubated in antibiotic-free medium with 10% fetal bovine serum (FBS) overnight. Cells were transfected with integrin-␤1 siRNA, ␤3-siRNA, or guanine-cytosine content-matched scrambled siRNA (50 pmol; Thermo Scientific, Waltham, Massachusetts) using Lipofectamine RNAiMAX (Invitrogen). After 24 hours, cells were treated with 0.25% trypsin and replated on new dishes for experiments.
Protein extraction and Western blot
Cells were lysed in radioimmunoprecipitation assay buffer (50 mM Tris-Cl, pH 7.4; 150 mM NaCl; 1% Nonidet P-40; 0.25% Na-deoxycholate) containing protease and phosphatase inhibitor cocktail. Protein concentrations were determined by Bradford assay. For Western blotting, 20 g of protein samples were resolved on SDS-PAGE and transferred to polyvinylidene fluoride membrane. The membrane was blocked with 5% nonfat milk in PBS with 0.05% Tween 20 at room temperature for 1 hour. Membrane was then blotted with various primary antibodies at 4°C overnight or at room temperature for 1 hour, washed 3 times with PBS with 0.05% Tween 20, and incubated with horseradish peroxidase-coupled secondary antibody. The primary antibodies were used with different dilutions (1:3000 for integrin-␤1; 1:1000 for integrin-␤3; 1:1000 for cyclin D1; 1:1000 for phosphorylated FAK; 1:2000 for FAK; and 1:10 000 for ␤-actin). Immunoreactivity was detected by using enhanced chemiluminescence detection kit (NEN/PerkinElmer, Wellesley, Massachusetts). Signal intensity was quantified by a BioSpectrum AC UVP image system (Upland, California).
Adhesion assay
Wells of 24-well tissue culture plates were coated with laminin (2 g/cm 2 ; Invitrogen) or fibronectin (1 g/cm 2 ; BD Biosciences). Wells were blocked for 1 hour at room temperature with 10 mg/mL heat-inactivated BSA and washed twice with PBS before adding cells. Cells (50 000/well) suspended in serum-free DMEM were incubated at 37°C for 30 minutes or 1 hour. Nonadherent cells were washed away with PBS, and cells were fixed in 5% glutaraldehyde in water. Cells were stained with 0.1% crystal violet for 25 minutes and then dissolved with lysis buffer (50% ethanol and 0.1% acetic acid in water) to obtain an absorbance reading at 570 nm.
Immunocytochemistry
To avoid cytosolic paxillin interference, we used CSK buffer [10 mM piperazine-N,NЈ-bis (2-ethanesulfonic acid), pH 6.8; 50 mM NaCl; 3 mM MgCl 2 ; 150 mM sucrose; 1 mM phenylmethylsulfonyl fluoride] to remove paxillin that was not recruited to focal adhesion sites. Cells were washed with ice-cold CSK buffer and incubated with CSK buffer with 0.1% Triton X-100 on ice for 2 minutes. Then the cells were fixed in 3.7% formaldehyde in PBS for 10 minutes at room temperature and then washed with PBS. Cells were blocked in blocking solution for 1 hour and followed by incubation with mouse antipaxillin antibody overnight at 4°C. After several washes with PBS, the cells were incubated with Alexa Fluor 488 goat antimouse IgG. Actin stress fibers were monitored by staining with Texas red-labeled phalloidin.
Cell spreading and stress fiber assembly
Cells (10 000/well) were resuspended in serum free DMEM and allowed to spread for 10 minutes to 2 hours on fibronectin or laminin-coated wells. Cells were fixed with 3.7% formaldehyde in PBS for 10 minutes at room temperature and permeabilized with 0.05% Triton X-100 in PBS for 10 minutes. F-actin was labeled by incubation with 0.1 g/mL Texas red-labeled phalloidin in blocking solution for 1 hour at room temperature. For quantification of cell spreading, at least 100 adherent cells (from randomly selected 10 fields in each well) were counted and the spreading areas were automatically calculated by the image processing software Image Pro Plus (Media Cybernetics, Bethesda, Maryland).
To quantify the proportion of leiomyomal cells with wellorganized stress fibers, at least 100 adherent cells (from randomly selected 10 fields in each well) were scored as having either well-organized or poorly organized stress fiber by 2 independent researchers. Cells with the organized, thickened parallel actin bundles throughout most the cytoplasm were defined as having well-organized stress fiber (17) . To avoid the influence of cell-cell contacts, only isolated cells were scored.
Collagen gel contraction
Twenty-four-well plates were coated with 1% BSA to create a nonstick surface that enables gel to detach from well easily. The collagen gel (3% type I collagen; 2ϫ DMEM; 0.25% NaHCO 3 ; 0.02 N NaOH; 0.02 M HEPES, pH 7.2) was prepared on ice and mixed with same volume of cells. Collagen gel-cell suspension (0.5 mL/well in 24 well plate) was added and incubated at 37°C for 20 minutes to allow gelling. Then 0.5 mL serum-free medium was added over the cell-collagen lattice. The collagen gel was monitored over a period of 72 hours by a BioSpectrum AC UVP image system. The surface areas were analyzed by the software Image Pro Plus software (Media Cybernetics).
Cell proliferation assay
Proliferation of cells was determined by crystal violet staining (described above) and bromodeoxyuridine (BrdU) incorporation assays. For BrdU incorporation assay, 10 M BrdU was added to culture medium and incubated for 24 hours. Cells were fixed in ice-cold fixation buffer (70% ethanol and 30% glycine, pH 2.0) for 30 minutes after aspiration of culture medium. After washing with PBS, cells were incubated with mouse anti-BrdU antibody (1:200; Santa Cruz Biotechnology) at 37°C for 30 minutes. Cells were then incubated with Alexa Flour 594-conjugated goat antimouse IgG antibody (1:500; Invitrogen) at 37°C for 30 minutes after washing with PBS. Signals were visualized under an epifluorescence microscope.
Disintegrin treatment
To determine the effect of blocking integrin-ECM binding on cell proliferation, cells were preincubated with rhodostomin (0.1-100 g/mL, a kind gift from Dr Woei-Jer Chuang, Department of Biochemistry and Molecular Biology, National Cheng Kung University) or PBS for 30 minutes at 37°C and followed by the addition of 10% FBS. At 72 hours after the FBS treatment, cells were fixed with 5% glutaraldehyde and then stained with 0.1% crystal violet. 
Statistical analysis
Statistical analysis was performed by either paired t test or 1-way ANOVA followed by Dunnett's multiple comparison test using Prism software (GraphPad Software Inc, San Diego, California). The results of experiments were showed as mean Ϯ SEM. P Ͻ .05 was considered as significant difference.
Results
Integrin-␤1 is overexpressed in leiomyomal cells
To study the functional role of integrins in leiomyomal development, we first quantified the expression levels of several integrins including integrin-␣4, integrin-␣5, integrin-␣v, integrin-␤1, integrin-␤3, integrin-␤4, and integrin-␤5 in 15 pairs of myometrial and leiomyomal tissues by Western blotting. Consistent with a previous report (18) , expression of integrins was not different among different stages of menstrual cycle (data not shown). Among all the major integrins analyzed, the levels of integrin-␤1 were significantly elevated in leiomyomal tissues compared with normal counterparts (Figure 1 ), whereas the levels of the other integrins were not different (Supplemental Figure 1) . Therefore, integrin-␤1 was chosen for subsequent studies.
Integrin-␤1 knockdown affects leiomyomal cell spreading but not adhesion
To investigate the function of integrin-␤1 in leiomyomal cells, we used siRNA to knock down integrin-␤1 in leiomyomal cells. The expression of integrin-␤1 in small interfering (si)-integrin-␤1-treated cells was reduced after being subcultured for 1 or 3 days. Quantification results indicated that the expression of integrin-␤1 in si-integrin-␤1-treated cells was reduced to 4.2% of si-scramble on day 1 and 7.3% on day 3 ( Figure 2, A and B ). There were no significant differences between si-scramble and mock control. In addition, the level of integrin-␤3 was not affected by the knockdown of integrin-␤1, indicating the specificity of si-integrin-␤1 (Figure 2, A and B) .
We first investigated whether the ability of adhesion to fibronectin or laminin is affected by integrin knockdown. The result showed that integrin-␤1 knockdown did not reduce leiomyomal cells adhesion on fibronectin, laminin, 
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or collagen matrix compared with si-scrambled control ( Figure 2C ). Next, we tested whether integrin-␤1 is required for leiomyomal cells spreading. As seen in Figure 3 , A and B, the cell-spreading area was increased in a time-dependent fashion when cells were plated on fibronectin-coated surface (si-scramble). However, cell spreading was significantly impaired in integrin-␤1 knockdown cells compared with si-scramble cells. The number of cells with well-organized stress fiber was also reduced in integrin-␤1 knockdown cells ( Figure 3C ). Similar results were also observed when cells were seeded on laminin-or collagen-coated surface (Supplemental Figure 2) .
To further confirm that integrin-␤1 is important in maintaining proper cell morphology and function, we used collagen gel contraction assay to test the tensional force of cell with or without integrin-␤1 knockdown. As shown in Figure 3D , the total gel area was much smaller in the integrin-␤1 intact group compared with the integrin knockdown group. Because the gel area is inversely correlated with the contraction force of cells, this result demonstrated that cells with intact integrin-␤1 have stronger tensional force than integrin-␤1 knockdown cells.
Activation of integrin-␤1 induces FAK phosphorylation and focal adhesion complex formation
To test the hypothesis that reduced cytoskeleton organization and cell spreading in integrin-␤1 knockdown cell is due to the disruption of focal adhesion complex, we examined the levels of FAK phosphorylation and focal adhesion complex formation in integrin intact and knockdown cells. The Western blot result showed that FAK was phosphorylated at 10 minutes after plating on the fibronectin-coated surface ( Figure 4A ). The level of FAK phosphorylation was further increased at 30 minutes after plating. Compared with the scrambled group, the phosphorylation of FAK was inhibited in the integrin-␤1 knockdown cells ( Figure 4A ).
We then tested whether reduced phosphorylation of FAK in the integrin-␤1 knockdown cells would result in inhibiting the activation of ERK. As seen in Figure 4B , phosphorylation of ERK was increased in control cells culturing on the fibronectin-coated surface. Levels of ERK phosphorylation was significantly reduced when integrin-␤1 was knocked down by siRNA ( Figure 4B) .
Next, we examined focal adhesion complex formation by detecting the colocalization of F-actin and paxillin. Im- munofluorescent staining showed scattered focal adhesion complex formed at 30 minutes after adhering to fibronectin surface, even though the cell still appears as a round shape with F-actin surrounding the cell edge ( Figure 4C ). At 2 hours after adhesion, control cells showed well-organized F-actin structure with clear paxillin staining. In contrast, integrin-␤1 knockdown cells were not spread out well with little or no paxillin colocalized with F-actin ( Figure 4C ). Similar results were seen when the cells were plated on the laminin-or collagen-coated surface (Supplemental Figure 3) .
Integrin-␤1 promotes leiomyomal cell proliferation
We then investigated whether reduced integrin-␤1 expression affects cell proliferation. Knockdown of integrin-␤1 decreased cyclin D1, a marker of cell cycle progression, expression at 12 and 24 hours after plating ( Figure 5 , A and B), indicating that cell cycle progression was inhibited. The effect is specific to integrin-␤1 because knockdown of integrin-␤3 had no substantial effect on cyclin D1 expression (Supplemental Figure 4) . Consistent with this finding, the cell proliferation rate was reduced in the integrin-␤1 knockdown group compared with the control group ( Figure 5, C-E) .
Disruption of integrin-ECM binding by rhodostomin inhibits cell proliferation
We then aimed to determine the therapeutic/intervention potential of blocking integrin-ECM interaction in leiomyoma therapy. The arginine-glycine-aspartic acid (RGD)-containing protein, rhodostomin, was administered to the culture medium and incubated with cells for 24 hours. Expression of cyclin D1 was reduced by addition of rhodostomin in a dose-dependent manner ( Figure 6 , A and B). Consistent with this notion, the cell proliferation rate was also inhibited by rhodostomin ( Figure 6 , C-E).
Discussion
Uterine leiomyoma is the most common gynecological disease with an enigmatic etiology. Uncontrolled cell prolif- 
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eration and excessive ECM production are 2 well-known hallmarks of this disease (3, 4) . However, whether there are any relationships between these 2 phenotypic characteristics have not been investigated. Herein we report that integrin-␤1, 1 of the 2 subunits of many ECM receptors, was up-regulated in leiomyomal cells compared with their myometrial counterparts. Integrin-␤1 served as the major receptor to transmit signals from ECM. Activation of integrin-␤1 caused FAK phosphorylation and then recruited paxillin to form focal adhesion complex, which is important for cell spreading and proper formation of cytoskeleton. All these cellular processes are required for the progression of the cell cycle as evidenced by the slower cell proliferation rate in integrin-␤1 knockdown cells. More importantly, we demonstrated that rhodostomin, a snake venom protein that specifically blocks the binding of ECM to integrin, inhibited cyclin D1 expression and cell proliferation. Collectively these data demonstrated that the upregulation of integrin-␤1 is an important factor contributing to the proliferation of leiomyomal cells and suggest that the disruption of the ECM-integrin-␤1 signaling may be an effective approach to inhibit leiomyoma progression.
The primary function of integrins in maintaining cellcell and cell-matrix adhesion is well documented. However, in addition to forming an adhesion complex, integrins are also important receptors for signals transmit from ECM to the intracellular compartment. Activation of integrins initiates signaling cascades promoting cell differentiation, proliferation, and survival via the recruitment of numerous adaptor and signaling proteins to the cytoplasmic tails of the integrin-␤-subunits (19) . Thus, when over- expressed in tumor cells, integrins usually contribute to cancer progression and malignancy by increasing tumor cell proliferation, survival, and metastasis (10) . In this study, we demonstrated that integrin-␤1 is overexpressed in leiomyomal cells compared with normal myometrial cells obtained from the same individual. Our data partially agreed with a previous report (18) in that integrin-␤1 is present in uterine myometrial and leiomyomal cells but disagreed in that leiomyomal cells expressed a greater level of integrin-␤1. The discrepancy is probably because different methods were used to measure the levels of integrins. Taylor et al (18) used immunostaining, which is not a quantitative measurement, to detect the presence of integrins, whereas we performed Western blot to quantify paired myometrial and leiomyomal cells from the same individual.
The elevation of integrin-␤1 in leiomyomal cells prompted us to investigate its functional role in the pathogenesis of leiomyoma. Because leiomyoma is a fast-growing solid tumor with tight cell-cell/cell-matrix adhesions, we hypothesized that elevated levels of integrin-␤1 may contribute to 1 or both of these 2 phenotypes. Surprisingly, we found that the knockdown of integrin-␤1 did not affect cell adhesion to fibronectin, laminin, or collagen. This is probably because the presence of other integrins may compensate for the loss of integrin-␤1. Indeed, it has been shown that integrin-␣v␤3 and -␣6␤4 can serve as receptor for fibronectin and laminin, respectively (7). Therefore, knockdown of integrin-␤1 alone is not sufficient to impair a cell's adhesion ability.
The binding of ECM to integrins initiates the phosphorylation of FAK, which then regulates the maturation of focal adhesion and cytoskeleton organization. The underlying meaning of this phenomenon is the proper organization of cytoskeleton so cells can maintain their morphology and even polarity. Proper organization of cytoskeleton controls many important cellular functions both in vitro and in vivo. Numerous studies have demonstrated the importance of integrin-dependent cytoskeleton organization in cell fate determination and disease development (8 -11) . Herein we demonstrated that the knockdown of integrin-␤1 reduced FAK phosphorylation, impeded the recruitment of paxillin, and thus inhibited the formation of focal adhesion and stress fibers. Collagen gel contraction assay further demonstrated that knockdown of integrin-␤1 reduced a cell's tensional force. Taken together, these data demonstrated that integrin-␤1 is an important receptor component for leiomyomal cells and its function in maintaining leiomyomal cell morphology is indispensable.
Uncontrolled proliferation is the hallmark of leiomyoma. Sex hormone (20) , protooncogene (16) , and numerous peptide growth factors (21) had been demonstrated to stimulate leiomyomal cells proliferation. Here we further demonstrated that integrin-␤1 can transmit growth signals from ECM. Although the precise mechanism remains largely unknown, numerous studies had demonstrated that activation of integrins can activate several signaling pathways such as Src, ERK, Rho, and protein kinase C to induce the expression of cyclin E and cyclin D1 (22) . Autophosphorylation of FAK after the binding of ECM to integrin is a critical step toward this cell cycle progression.
In this study, we demonstrated that the phosphorylation of FAK and its downstream kinase, ERK, was evident when leiomyomal cells were plated to a fibronectin-coated matrix. However, the levels of FAK and ERK phosphorylation were decreased and the expression of cyclin D1 was inhibited in integrin-␤1 knockdown leiomyomal cells. The cell proliferation rate of integrin-␤1 knockdown cells was also attenuated compared with that of scrambled control cells. Our data are consistent with previous reports in skeletal muscle and cartilage (23, 24) and provide clear evidence to demonstrate that integrin-␤1 indeed plays an important role contributing to the growth of leiomyomal cells.
Excessive production of ECM in leiomyomal cells has been known for decades; however, the functional role of these ECM in leiomyoma pathogenesis remains unclear. In this report, we demonstrated that one of the receptors for these ECMs, integrin-␤1, was overexpressed in leiomyomal cells, and it plays a critical role in mediating leiomyomal cell spreading, cytoskeleton organization, and cell proliferation. Our findings not only reveal the pathological function of ECM-integrin-␤1 axis in the development of leiomyoma but also provide valuable information for designing new treatment regimens that target the interaction of ECM and integrins. Recent studies have shown that anti-RGD peptides are potent drugs in blocking integrin signaling and, thus inducing apoptosis of cancer cells (25, 26) . Indeed, we also demonstrated that the treatment of leiomyomal cells with rhodostomin inhibits cell proliferation. Rhodostomin is obtained from Calloselasma rhodostoma venom and belongs to the family of disintegrins, which mainly inhibit the functions of ␤1-and ␤3-associated integrins (27) . Considering the recent advances in anti-RGD drugs, our findings may shed light on developing new strategies for the treatment of uterine leiomyoma. Further studies to investigate the underlying mechanism of disintegrin in leiomyomal cell apoptosis using animal models should be able to provide even more fruitful outcomes.
